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Survival Prediction with A Combination of
Machine Learning Technologies
Rui Xu, Xindi Cai, and Donald C. Wunsch II
Applied Computational Intelligence Laboratory, Dept. of Electrical and Computer Engineering
University of Missouri – Rolla, Rolla, MO 65409-0249 USA
networks, i.e., particle swarm optimization (PSO) and
probabilistic neural networks (PNN), to perform survival
analysis on a diffuse large B-cell lymphoma (DLBCL) data
set [5]. PSO is an evolutionary computation technique for
global optimization, which is based on the simulation of
complex social behavior [12]. We use PSO to address one of
the major challenges of microarray data analysis: the
overwhelming number of measures of gene expression
levels compared with the small number of samples. This is
known as the curse of dimensionality [15]. Not all of these
genes (features) are relevant to a specific tumor type, and
the inclusion of the unrelated genes in the data analysis not
only increases the computational complexity, but makes the
results hard to interpret and prevents determining the
appropriate therapy. Therefore, gene selection is critically
important. By using PSO in gene selection, we consider the
ability of PSO to balance global and local exploration, its
effectiveness in achieving high-quality solutions, and the
memory mechanism for keeping track of previous best
solutions and therefore, avoiding the possible loss of
previously learned knowledge. PNN was introduced as an
implementation of nonparametric Pazen window estimation
with feed-forward neural network architecture [14]. PNN
has the advantage of fast training, only one user dependent
parameters, and the capability to approximate arbitrarily
complex decision boundaries, and has already shown
appealing performance in cancer identification [2].
The paper is organized as follows. Section II describes
the PSO/PNN system for survival analysis. The
experimental results on DLBCL data set are presented and
discussed in section III. Section IV concludes the paper.

Abstract—Gene expression profiles have become an
important and promising way for cancer prognosis and
treatment. In addition to their application in cancer class
prediction and discovery, gene expression data can be used for
the prediction of patient survival. Here, we use particle swarm
optimization (PSO) to address one of the major challenges in
gene expression data analysis, the curse of dimensionality, in
order to discriminate high risk patients from low risk patients.
A discrete binary version of PSO is used for gene selection and
dimensionality reduction, and a probabilistic neural network
(PNN) is implemented as the classifier. The experimental
results on the diffuse large B-cell lymphoma data set
demonstrate the effectiveness of PSO/PNN system in survival
prediction.
Keywords—Gene expression data, Probabilistic neural
networks, Particle swarm optimization, Cancer survival
prediction.

I. INTRODUCTION
Gene expression profiles have become an important and
promising way for cancer prognosis and treatment.
Particularly, their applications for cancer class prediction
and discovery have already attracted numerous efforts from
a wide variety of research communities [1-4]. On the other
hand, prediction of patient survival, based on gene
expression profiles, is also useful in choosing appropriate
therapy [3-11]. This link provides an effective means to
overcome the insufficiency of traditional methods in cancer
research, which are largely dependent on the morphological
appearance of tumors or the parameters derived from
clinical observations. Several studies have been done for
patient survival analysis based on either hierarchical
clustering or statistical regression [3-11]. For example,
Garber et al. used hierarchical clustering to divide
adenocarcinoma tumors into three groups, and significant
differences in patient survival rates is observed in these
groups [4]. Bair and Tibshirani calculated the Cox score to
find genes whose expression levels are correlated with
patient survival and only performed clustering on the
selected important high-scored genes [8]. However,
machine learning and neural network technologies, which
have achieved many appealing results in microarray data
analysis, are also worth exploring for this problem.
Here, we propose a hybrid system, consisting of two
important technologies in machine learning and neural
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II. METHODS
PSO is motivated by the behavior of bird flocking or
fish schooling and originally intended to explore optimal or
near-optimal solutions in sophisticated continuous spaces
[12]. A randomized velocity is associated with each
potential solution, called a particle in the swarm. These
particles change their positions in the search space until a
stop condition is satisfied. The basic idea of PSO is to
accelerate each particle towards two best locations at each
time step, where one is the previous best solution for the
particle, based on the calculated fitness value, and the other
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classification accuracy and n is the number of genes
selected.
iii). Compare the fitness value of the ith particle with its
previous best position pi. If the current value is better
than pi, reset both pi and location to the current value
and location.
iv). Compare the fitness value of each particle with the
global best position pg. If current value is better than
pg, reset pg to the current particle’s array index and
value.
v). Update the velocity and position of the particle with
the following equations.
vid = w × vid + c1 × ϕ1 × ( pid − xid )
(2)
+ c2 × ϕ 2 × ( pgd − xid )

xi(t+1)

vi(t+1)

c2ĳ2(pg- xi(t))

c1 ĳ1 (pi- xi(t))
xi(t)

w vi(t)

Fig. 1. . Concept of a swarm particle’s position. xi(t) and vi(t) denote the
particle’s position and the associated velocity vector in the searching
space at generation t, respectively. Vector c1 ĳ1 (pi- xi(t)) and c2 ĳ2 (pgxi(t)) describe the particle’s “cognitive” and “social” activities,
respectively. The new velocity vi(t+1) is determined by the momentum
part, “cognitive” part, and “social” part. The particle’s position at
generation t+1 is updated with xi(t) and vi(t+1).

⎧1 if ϕ3 + δ < S (vid )
xid = ⎨
(3)
otherwise
⎩ 0,
where xid and vid are the position and velocity of the
dth dimensionality of the ith particle, respectively, w
is the inertia weight, c1 and c2 are the acceleration
constants, ĳ1, ĳ2, and ĳ3 are uniform random
functions in the range of [0, 1], į is a parameter that
limits the total number of genes selected to some
certain range, and S() is the sigmoid function.
Compared with the original binary PSO in [13], we
add the parameter į in order to control the number of
selected genes more flexibly.
vi). Return to step ii until the stop condition is satisfied,
usually a maximum number of iterations or highquality solutions.
The velocity update of a PSO particle in (2) comprises
three parts. The first is the momentum part, which prevents
abrupt velocity change. The second is the “cognitive” part,
which represents learning achieved from its own search
experience. The third is the “social” part which represents
the cooperation among particles – learning from the group
best’s search experience. The inertia weight w controls the
balance of global and local search ability. A large w
facilitates the global search while a small w enhances local
search. The velocity for each particle is restricted to a limit
Vmax. During the evolutionary procedure, the velocity is reassigned to Vmax if it exceeds Vmax. For binary PSO, this
limits the probability that a bit in a particle takes on the
value of one. Usually, the smaller Vmax is, the higher the
mutation rate [13].
A typical PNN architecture is illustrated in Fig. 2,
which consists of three layers: input layer, pattern layer and
category layer [14-15]. The input layer works as a
distribution mechanism and receives input components from
the data set. Therefore, the number of nodes in this layer is
equal to the dimension of the input vector. All of these
nodes are fully connected with the nodes in the pattern
layer, which is considered as the key of PNN. PNN requires
m pattern nodes if the total number of training patterns is m,
so that each pattern node can correspond to a training
pattern. In contrast to the link between input and pattern

is the best overall value in the whole swarm. The basic
concept of PSO is depicted in Fig. 1.
Since our goal is to select a subset of important genes
(features) from a large gene pool and therefore reduce the
dimensionality, we use a discrete binary version of PSO
[13]. The major change of the binary PSO comes from the
re-explanation of the meaning of the particle velocity. Given
a set of particles X = ( x1 , x 2 ,..., x N ) , where N is the number

of particles in the swarm, the velocity for the ith particle
xi = ( xi1 , xi 2 ,..., xiD ) , where D is the number of dimensions

in a particle, is represented as vi = ( vi1 , vi 2 ,..., viD ) . The
possible values for each bit xid ( 1 ≤ i ≤ N , 1 ≤ d ≤ D ) is
either one or zero, indicating whether the corresponding
genes are selected or not. Its velocity vid is explained as the
probability that xid takes the value of one, and is squashed
into the interval [0,1] through a logistic function
S (vid ) = 1/(1 + exp(−vid )) . The basic procedure of binary
PSO for gene selection is as follows:
i). Initialize a population of N particles with random
positions and velocities. The dimensionality D of the
problem space is dependent on the number of genes
in the data set.
ii). Evaluate the classification performance of the
classifier and calculate the optimization fitness
function for each particle. Here, the design of fitness
function aims to minimize the classification error and
also favor the subset with fewer genes, which is
defined as
f (xi ) = AccLOOCV + 1/ n ,
(1)
number of correctly
classified patients
× 100% is
where AccLOOCV =
total number of patients
the leave one out cross validation (LOOCV) [15]
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survival time (2.8 years) is placed into the low-risk group,
otherwise, into the high-risk group. For those censored
patients who left the follow-up before the median, we
estimated the probability of their survival according to the
Kaplan-Meier survival curve and then assigned its label.
During the training phase, we used leave one out cross
validation as the error estimation for gene selection. Each
time, a different single sample was left out as the test point
and the other samples were used for training. Then we
evaluated the prediction performance of the classifier on the
independent test set.
We set the parameters for PSO as follows: w=0.7,
c1 = c2 = 2 , and Vmax=2. We adjusted the value of į in order
to control the total number of selected genes in the subsets.
Each time, the evolution is processed for 200 generations
with 30 particles included in the swarm. The smoothing
parameter of the Gaussian kernel is set to 2. Unlike other
algorithms, we only have four parameters that are userdependent. Their values can be easily determined and the
performance is not sensitive to their change [2]. Fig.3 shows
the Kaplan-Meier curves for the estimation of patient
survival in the training set and the test set, respectively. We

Category
Units

Pattern
Units
Input
Units
x1

xj

xp

Fig. 2. PNN architecture. Each pattern node represents a pattern in the
training set. The Bayesian posterior probability for each category is
obtained as the output of the corresponding category node.

layers, the nodes of pattern and category layers are sparsely
connected. Each pattern node is only connected to the
category node that correctly indicates its associated class.
PNN calculates the Bayesian posterior probability for each
category. During the training phase, the weights connecting
the input and pattern layer are simply set as the copy of
input vectors, i.e. w i = x i , for i = 1,..., n . This process is
one of the fastest known training strategies. During the test
phase, each pattern node performs a dot product operation
with a new pattern vector x and a weight vector w i ,
expressed as Pi = x • w i . The final output pattern layer is
obtained via a nonlinear transformation. Usually a Gaussian
activation function exp ( ( Pi − 1) / σ 2 ) is used. Here, σ is the
smoothing parameter of the Gaussian kernel and is also the
only user-dependent parameter. Note that if both the training
patterns and the new patterns are normalized to unit length,
the output of pattern layer can be represented as
exp ( Pi − 1) / σ 2

(

)

(
= exp(− (x − w i )

= exp − (x x + w i T w i − 2x T w i ) / 2σ 2
T

T

2

)

),

(4)

(a)

(x − w i ) / 2σ
which is identical to the Parzen window function. In this
sense, each pattern node provides the corresponding
category node with the class conditional probability given
the training pattern. These values are then summed up in the
category layer for each category as the estimated probability
for the new pattern. The label of the pattern can be predicted
by just choosing the maximum probability.
III. RESULTS
We performed the survival analysis on the DLBCL data
set of Resenwald et al., which consists of measurements of
7,399 genes from 240 patients [5]. The data set is divided
into a training set with 160 patients and a test set with 80
patients. The survival time for the patients ranges from 0 to
21.8 years. Any patient who lived longer than the median

(b)
Fig. 3. Kaplan-Meier curves show significant differences in survival of
the high-risk and low-risk group, based on the performance of PSO/PNN
on the training set (a) and the independent test set (b).
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set į as 0.49, which leads to the selection about 92-185
genes. We chose the subset consisting of 113 genes that can
achieve 80% classification accuracy on the test set and drew
the curves. We also increased or decreased the value of į to
check the effect of gene subsets on the classification rate.
We find in both ways, the performance is deteriorated. For
example, the best result for the subsets including 5-30 genes
is 73%. When all genes are used, the classification accuracy
is only 52%. These results reflect the importance of gene
selection in the prediction of clinical phenotypes, as its
application in tumor classification [1-2]. We applied the logrank test to test the difference between the low-risk and
high-risk group, each of which is associated with a survival
curve, as depicted in Fig. 3. The p-values for both the
training set and the test set are less than 0.0001, which
indicates the significant difference between the two risk
groups, divided by the PSO/PNN method. There are 11
patients with less than 2.8 years survival time that are
misclassified into the low-risk group in the test set. For the 5
misclassifications in the high-risk group, four of them are
censored and the other is a patient died at 3.1 years.
Furthermore, we calculated the frequency of each gene
appearing in the selected 210 subsets. We find that the
selection frequencies of 5 genes are more than 13% and
those of 34 genes are more than 10%. This shows that PSO
tends to choose a subset of genes associated with the
phenotype in spite of the different initial conditions.
However, the challenge to find the relation of genes with the
survival still remains open due to the existing uncertain
factors [16].

REFERENCES
[1] T. Golub, D. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J.
Mesirov, H. Coller, M. Loh, J. Downing, M. Caligiuri, C. Bloomfield,
and E. Lander, “Molecular classification of cancer: Class discovery
and class prediction by gene expression monitoring,” Science, vol.
286, pp. 531-537, 1999.
[2] R. Xu, and D. Wunsch, “Probabilistic neural networks for multi-class
tissue classification with gene expression data,” Proceedings of
International Joint Conference on Neural Networks 03, vol. 3, pp.
1696-1701, 2003.
[3] D. Beer, S. Kardia, C. Huang, T. Giordano, A. Levin, D. Misek, L.
Lin, G. Chen, T. Gharib, D. Thomas, M. lizyness, R. kuick, S.
Hayasaka, J. Taylor, M. Iannettoni, M. Orringer, and S. Hanash,
“Gene-expression profiles predict survival of patients with lung
adenocarcinoma,” Nature Medicine, vol. 8, no. 8, pp. 816-824, 2002.
[4] M. Garber, O. Troyanskaya, K. Schluens, S. Petersen, Z. Thaesler, M.
Pacyna-Gengelbach, M. Rijn, G. Rosen, C. Perou, R. Whyte, R.
Altman, P. Brown, D. Botstein, and I. Petersen, “Diversity of gene
expression in adenocarcinoma of the lung,” Proc. of Natl. Acad. Sci.,
vol. 98, no. 24., pp. 13784-13789, 2001.
[5] A. Rosenwald, G. Wright, W. Chan, J. Connors, C. Campo, R. Fisher,
R. Gascoyne, H. Muller-Hermelink, E. Smeland, and L. Staudt, “The
use of molecular profiling to predict survival after chemotherapy for
diffuse large-B-cell lymphoma,” The New England Journal of
Medicine, vol. 346, no. 25, pp. 1937-1947, 2002.
[6] M. Vijver, Y. He, L. Veer, H. Dai, A. Hart, D. Voskuil, G. Schreiber,
J. Peterse, C. Roberts, M. Marton, M. Parrish, D. Atsma, A.
Witteveen, A. Glas, L. Delahaye, T. Velde, H. Bartelink, S.
Rodenhuis, E. Rutgers, S. Friend, and R. Bernards, “A geneexpression signature as a predictor of survival in breast cancer,” The
New England Journal of Medicine, vol. 347, no. 25, pp. 1999-2009,
2002.
[7] G. Glinsky, A. Glinskii, A. Stephenson, R. Hoffman, and W. Gerald,
“Gene expression profiling predicts clinical outcome of prostate
cancer,” J. Clin. Invest. vol. 113, pp. 913-923, 2004.
[8] E. Bair and R. Tibshirani, “Semi-supervised methods to predict
patient survival from gene expression data,” PLoS Biology, vol. 2, no.
4, pp. 511-522, 2004.
[9] M. Shipp, K. Ross, P. Tamayo, A. Weng, J. Kutok, R. Aguiar, M.
Gaasenbeek, M. Angelo, M. Reich, G. Pinkus, T. Ray, M. Koval, K.
Last, A. Norton, T. Lister, J. Mesirov, D. Neuberg, E. Lander, J.
Aster, T. Golub, “Diffuse large B-cell lymphoma outcome prediction
by gene expression profiling and supervise machine learning,” Nature
Medicine, vol. 8, no. 1, pp. 68-74, 2002.
[10] T. Sørlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T.
Hastie, M. Eisen, M. Rijn, S. Jeffrey, T. Thorsen, H. Quist, J.
Matese, P. Brown, D. Botstein, P. Lønning, and A. Børresen-Dale,
“Gene expression patterns of breast carcinomas distinguish tumor
subclasses with clinical implications,” Proc. of Natl. Acad. Sci., vol.
98, no. 19, pp. 10869-10874, 2001.
[11] L. Li and H. Li, “Dimension reduction methods for microarrays with
application to censored survival data,” Bioinformatics, vol. 18, pp.
3406-3412, 2004.
[12] J. Kennedy, R. Eberhart, Y. Shi, “Swarm intelligence,” Morgan
Kaufmann Publishers, 2001.
[13] J. Kennedy and R. Eberhart, “A discrete binary version of the particle
swarm optimization,” Proc. of Conf. on System, Man, and
Cybernetics, pp. 4104-4108, 1997.
[14] D. Specht, “Probabilistic Neural Networks,” Neural Networks, vol. 3,
pp. 109-118, 1990.
[15] R. Duda, P. Hart, and D. Stork, Pattern classification, 2nd Ed.. Wiley
& Sons, New York, 2001.
[16] L. Ein-Dor, I. Kela, G. Getz, D. Givol, and E. Domany, “Outcome
signature genes in breast cancer: is there a unique set?,”
Bioinformatics, vol. 21, pp. 171-178, 2005.

IV. CONCLUSION
We have proposed a PSO/PNN system for the analysis
of patient survival through their gene expression profiling,
which can be a significant factor for pharmaceutical
selection and treatment. PSO is an effective computational
technique for global optimization, in this case, for the
selection of a subset of genes relevant to the phenotype.
This process, which is also can be regarded as
dimensionality reduction, is critically important in this type
of analyses since cancer data sets usually consist of
overwhelming number of measurements of gene expression
levels compared with a very small set of samples. The
experiment results on the DLBCT data set demonstrate that
the methods can be very useful in connecting the clinical
observance with gene expression profiling. Further research
includes the simulation study on more survival data sets, the
further investigation of the selected genes, and the
application of a hybrid of PSO and evolutionary algorithm
(EA) for gene selection. This design considers the
complementary properties of PSO and EA and is more
powerful for optimization.
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